FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034132874> ?p ?o ?g. }

• W2034132874 endingPage "2430" @default.
• W2034132874 startingPage "2422" @default.
• W2034132874 abstract "The increase of eukaryotic translation initiation factor 4E (eIF4E) expression is frequently observed in several types of cancer, making eIF4E an attractive anticancer drug target. However, the role of eIF4E in gastric cancer pathogenesis remains unclear. Perifosine is a bioavailable alkylphospholipid exhibiting antitumor activity in a series of cancer types. In this study, gastric cancer cell lines were selected to explore the role of eIF4E as a potential target for treating human gastric cancer. The expression of total eIF4E (T-eIF4E)and phosphorylated eIF4E (p-eIF4E) in gastric cancer samples was detected by immunohistochemical assay. RNA interference was used to silence eIF4E expression. Sulforhodamine B assay was performed to evaluate tumor cell viability. Colony formation assay was used to examine the effects of eIF4E small interfering RNA (siRNA) or perifosine on colony formation. The mRNA levels of eIF4E were analyzed by qRT-PCR and western blot analysis was carried out to evaluate the expression of Akt and eIF4E. The results showed that increased expression levels of T-eIF4E and p-eIF4E were found in gastric cancer tissues and cells. Reduced eIF4E expression blocked the proliferation of gastric cancer cells. Perifosine downregulated the T-eIF4E and p-eIF4E levels in a dose- and time-dependent manner; it also inhibited the growth of gastric cancer cells. Moreover, this inhibitory effect was significantly enhanced by the combination of eIF4E siRNA and perifosine treatments. Our results indicate that eIF4E gene silencing can inhibit tumor cell growth, and eIF4E can be developed as a promising therapeutic target for gastric cancer." @default.
• W2034132874 created "2016-06-24" @default.
• W2034132874 creator A5016950757 @default.
• W2034132874 creator A5017433297 @default.
• W2034132874 creator A5035869006 @default.
• W2034132874 creator A5036665185 @default.
• W2034132874 creator A5039510267 @default.
• W2034132874 creator A5063900505 @default.
• W2034132874 creator A5068744621 @default.
• W2034132874 creator A5090702667 @default.
• W2034132874 date "2013-04-09" @default.
• W2034132874 modified "2023-10-16" @default.
• W2034132874 title "Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth" @default.
• W2034132874 cites W1571056179 @default.
• W2034132874 cites W1929767597 @default.
• W2034132874 cites W1964675052 @default.
• W2034132874 cites W1968260551 @default.
• W2034132874 cites W1980534599 @default.
• W2034132874 cites W1992925022 @default.
• W2034132874 cites W1995434120 @default.
• W2034132874 cites W2000663742 @default.
• W2034132874 cites W2005234434 @default.
• W2034132874 cites W2007650725 @default.
• W2034132874 cites W2011360946 @default.
• W2034132874 cites W2012889132 @default.
• W2034132874 cites W2032319312 @default.
• W2034132874 cites W2049053321 @default.
• W2034132874 cites W2051916337 @default.
• W2034132874 cites W2083824275 @default.
• W2034132874 cites W2088816305 @default.
• W2034132874 cites W2091226837 @default.
• W2034132874 cites W2099110265 @default.
• W2034132874 cites W2126386849 @default.
• W2034132874 cites W2134052952 @default.
• W2034132874 cites W2137132167 @default.
• W2034132874 cites W2138504960 @default.
• W2034132874 cites W2147168993 @default.
• W2034132874 cites W2155691517 @default.
• W2034132874 doi "https://doi.org/10.3892/or.2013.2397" @default.
• W2034132874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23588929" @default.
• W2034132874 hasPublicationYear "2013" @default.
• W2034132874 type Work @default.
• W2034132874 sameAs 2034132874 @default.
• W2034132874 citedByCount "37" @default.
• W2034132874 countsByYear W20341328742013 @default.
• W2034132874 countsByYear W20341328742014 @default.
• W2034132874 countsByYear W20341328742015 @default.
• W2034132874 countsByYear W20341328742016 @default.
• W2034132874 countsByYear W20341328742017 @default.
• W2034132874 countsByYear W20341328742018 @default.
• W2034132874 countsByYear W20341328742019 @default.
• W2034132874 countsByYear W20341328742020 @default.
• W2034132874 countsByYear W20341328742021 @default.
• W2034132874 countsByYear W20341328742022 @default.
• W2034132874 countsByYear W20341328742023 @default.
• W2034132874 crossrefType "journal-article" @default.
• W2034132874 hasAuthorship W2034132874A5016950757 @default.
• W2034132874 hasAuthorship W2034132874A5017433297 @default.
• W2034132874 hasAuthorship W2034132874A5035869006 @default.
• W2034132874 hasAuthorship W2034132874A5036665185 @default.
• W2034132874 hasAuthorship W2034132874A5039510267 @default.
• W2034132874 hasAuthorship W2034132874A5063900505 @default.
• W2034132874 hasAuthorship W2034132874A5068744621 @default.
• W2034132874 hasAuthorship W2034132874A5090702667 @default.
• W2034132874 hasBestOaLocation W20341328741 @default.
• W2034132874 hasConcept C104317684 @default.
• W2034132874 hasConcept C105580179 @default.
• W2034132874 hasConcept C119056186 @default.
• W2034132874 hasConcept C121608353 @default.
• W2034132874 hasConcept C149364088 @default.
• W2034132874 hasConcept C161295673 @default.
• W2034132874 hasConcept C22615655 @default.
• W2034132874 hasConcept C2781018059 @default.
• W2034132874 hasConcept C29537977 @default.
• W2034132874 hasConcept C502942594 @default.
• W2034132874 hasConcept C54009773 @default.
• W2034132874 hasConcept C54355233 @default.
• W2034132874 hasConcept C55493867 @default.
• W2034132874 hasConcept C62112901 @default.
• W2034132874 hasConcept C67082663 @default.
• W2034132874 hasConcept C81885089 @default.
• W2034132874 hasConcept C86803240 @default.
• W2034132874 hasConcept C96232424 @default.
• W2034132874 hasConceptScore W2034132874C104317684 @default.
• W2034132874 hasConceptScore W2034132874C105580179 @default.
• W2034132874 hasConceptScore W2034132874C119056186 @default.
• W2034132874 hasConceptScore W2034132874C121608353 @default.
• W2034132874 hasConceptScore W2034132874C149364088 @default.
• W2034132874 hasConceptScore W2034132874C161295673 @default.
• W2034132874 hasConceptScore W2034132874C22615655 @default.
• W2034132874 hasConceptScore W2034132874C2781018059 @default.
• W2034132874 hasConceptScore W2034132874C29537977 @default.
• W2034132874 hasConceptScore W2034132874C502942594 @default.
• W2034132874 hasConceptScore W2034132874C54009773 @default.
• W2034132874 hasConceptScore W2034132874C54355233 @default.
• W2034132874 hasConceptScore W2034132874C55493867 @default.
• W2034132874 hasConceptScore W2034132874C62112901 @default.
• W2034132874 hasConceptScore W2034132874C67082663 @default.

• next